Greg Boustead Consultant Urological Surgeon

PCA3 test - the latest genetic test to determine your risk of having prostate cancer
This test can be done easily during a consultation and costs Ł350 + the consultation fee. For further information download this leaflet. PCA3.pdf

New prostate cancer drugs: trial drugs entering final phases of development

Zibotentan (ZD4054)- a specific endothelin-A receptor antagonist

A Phase III, Randomised, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 10 mg in Non-metastatic Hormone-resistant Prostate Cancer Patients.
If you are a prostate cancer patient, and you have a rising PSA while receiving hormone therapy, you may be eligible to enter this study. Please contact Mr Boustead via his NHS secretary to receive further information.

Abiraterone for advanced prostate cancer

Abiraterone is a new hormone therapy drug that researchers are looking into for prostate cancer. It is also called CB7630 or abiraterone acetate. For more information click below
http://www.cancerhelp.org.uk/help/default.asp?page=39986

Botox^TM for urinary incontinence

Botulinum-A toxin is licensed for a number of conditions (see link below). Botox^TM injections directly into the bladder are an alternative to invasive surgery for patients with disabling urge incontinence in whom conservative measures and conventional drugs have failed. Botox™ is not licencsed for this yet.
Clinical studies with different dosages and injection protocols show success rates of 60-96% for neurologically damaged bladders (like MS) and non-neurological bladder overactivity (OAB wet). The treatment lasts 6-12 months. The drug is still under ongoing investigation.
Mr Boustead can offer suitable patients Botox^TM therapy on a named patient basis. For more info click below
http://www.ncbi.nlm.nih.gov

TRT for stress incontinence

The Tension free readjustable tape is a novel incontinence sling which I use specifically for women with problematic stress incontinence who have had previous surgical failures and continue to leak.
The male sling may be suitable for men with post-prostatectomy urinary incontinence(MRS)
TRT has the unique ability to be adjusted immediately after surgery and again at a later point if required.
Mr Boustead has 5 years experience with this device and was one of the first Urologists in the UK to offer this procedure. For more information click below.
http://www.remeex.com/index.php?id_seccio_menu=12